Explore more publications!

Guinea Bissau Health Bulletin: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guinea Bissau Health Bulletin.

Press releases published on October 28, 2025

Madrigal to Present New Data from the Company’s MASH Program at AASLD’s The Liver Meeting 2025
Reviva to Present Negative Symptom Data for Brilaroxazine in Schizophrenia from the Phase 3 RECOVER Double-Blind and Open-Label Extension Trials at the CNS Summit 2025
Josh Ruben Joins PetVivo Holdings, Inc. Board of Directors
Nautilus Biotechnology Reports Third Quarter 2025 Financial Results
R1 Welcomes Estelle Barnes to Lead Enterprise Customer Engagement and Partnerships
ORYZON Strengthens Regulatory Strategy with the Appointment of Dr. Iman Barilero as Senior Advisor for Regulatory Affairs
Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements
Medela AG Launches «With You, Every Step of the Way» to Celebrate the Everyday Journey of Motherhood
Cingulate Presents Positive Phase 3 Results for CTx-1301 Demonstrating Statistically Significant Efficacy and Entire Active-Day Symptom Control
OPKO Health’s ModeX Therapeutics Begins Clinical Trial of MDX2004 for the Treatment of Advanced Cancers
ProPhase Labs Engages RedChip Companies to Lead Investor Relations Efforts
Emergent BioSolutions Releases New Survey Findings Revealing Heightened Concerns About Biological Threats and U.S. Preparedness
BioNTech veranstaltet am 11. November 2025 „Innovation Series Day“ zu Forschung & Entwicklung
BioNTech to Host Innovation Series R&D Day on November 11, 2025
Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study
Evidence Against Evidence: CERN-IEEE FPGA vs. Crosetto 3D-Flow, a Breakthrough Invention Recognized 32 Years Ago That Could Have, and Can Still, Save Billions of Euros and Millions of Lives
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution
Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season
Context Therapeutics to Participate in Upcoming Investor Conferences
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions